Comparison of fracture risk prediction among individuals with reduced and normal kidney function

Kyla L. Naylor, Amit X. Garg, Guangyong Zou, Lisa Langsetmo, William D. Leslie, Lisa Ann Fraser, Jonathan D. Adachi, Suzanne Morin, David Goltzman, Brian Lentle, Stuart A. Jackson, Robert G. Josse, Sophie A. Jamal

Research output: Contribution to journalArticlepeer-review

112 Scopus citations


Background and objectives The Fracture Risk Assessment Tool (FRAX) is widely used to predict the 10-year probability of fracture; however, the clinical utility of FRAX in CKD is unknown. This study assessed the predictive ability of FRAX in individuals with reduced kidney function compared with individuals with normal kidney function. Design, setting, participants, & measurements The discrimination and calibration (defined as the agreement between observed and predicted values) of FRAX were examined using data from the Canadian Multicentre Osteoporosis Study (CaMos). This study included individuals aged ≥40 years with an eGFR value at year 10 of CaMos (defined as baseline). The cohort was stratified by kidney function at baseline (eGFR<60 ml/min per 1.73 m2 [72.2% stage 3a, 23.8%stage 3b, and 4.0% stage 4/5] versus≥60ml/min per 1.73m2) and followed individuals for a mean of 4.8 years for an incidentmajor osteoporotic fracture (clinical spine, hip, forearm/wrist, or humerus). Results Therewere 320 individualswith an eGFR<60 ml/min per 1.73m2 and 1787with an eGFR≥60 ml/min per 1.73 m2. The mean age was 67610 years and 71% were women. The 5-year observed major osteoporotic fracture riskwas 5.3% (95% confidence interval [95% CI], 3.3% to 8.6%) in individuals with an eGFR<60 ml/min per 1.73 m2, which was comparable to the FRAX-predicted fracture risk (6.4% with bone mineral density; 8.2% without bone mineral density). A statistically significant difference was not observed in the area under the curve values for FRAX in individuals with an eGFR<60 ml/min per 1.73 m2 versus ≥60 ml/min per 1.73 m2 (0.69 [95% CI, 0.54 to 0.83] versus 0.76 [95% CI, 0.70 to 0.82]; P=0.38). Conclusions This study showed that FRAX was able to predict major osteoporotic fractures in individuals with reduced kidney function; further study is needed before FRAX should be routinely used in individuals with reduced kidney function.

Original languageEnglish (US)
Pages (from-to)646-653
Number of pages8
JournalClinical Journal of the American Society of Nephrology
Issue number4
StatePublished - 2015

Bibliographical note

Publisher Copyright:
© 2015 by the American Society of Nephrology.


Dive into the research topics of 'Comparison of fracture risk prediction among individuals with reduced and normal kidney function'. Together they form a unique fingerprint.

Cite this